EU-Approval for Ramucirumab (CYRAMZA®) for the Treatment of advanced Gastric Cancer after previous Chemotherapy

被引：0
|
作者：
Fauth, Elisabeth [1 ]
机构：
[1] 3K Agentur Kommunikat GmbH, D-60232 Frankfurt, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2015年 / 38卷 / 1-2期
关键词：
PHASE-3; TRIAL;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：74 / 74
页数：1
相关论文
共 50 条
  • [1] First approved Therapy for Second-line in EU EU-Approval for Ramucirumab (CYRAMZA((R))) for the treatment of advanced Gastric Cancer after prior Chemotherapy
    Fauth, Elisabeth
    VISZERALMEDIZIN, 2015, 31 (01): : 63 - 63
  • [2] EU-Approval for Elocta® (rFVIIIFc) for the Treatment and Prophylaxis of Hemophilia A
    Gerlach, Carmen
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2016, 43 (01) : 55 - 55
  • [3] Bronchobiliary fistula after ramucirumab treatment for advanced gastric cancer: A case report
    Hong-Beum Kim
    Yong Sub Na
    Hee-Jeong Lee
    Sang-Gon Park
    World Journal of Clinical Cases, 2019, 7 (19) : 3039 - 3046
  • [4] FDA Approval Summary: Ramucirumab for Gastric Cancer
    Casak, Sandra J.
    Fashoyin-Aje, Ibilola
    Lemery, Steven J.
    Zhang, Lillian
    Jin, Runyan
    Li, Hongshan
    Zhao, Liang
    Zhao, Hong
    Zhang, Hui
    Chen, Huanyu
    He, Kun
    Dougherty, Michele
    Novak, Rachel
    Kennett, Sarah
    Khasar, Sachia
    Helms, Whitney
    Keegan, Patricia
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2015, 21 (15) : 3372 - 3376
  • [5] Bronchobiliary fistula after ramucirumab treatment for advanced gastric cancer: A case report
    Kim, Hong-Beum
    Na, Yong Sub
    Lee, Hee-Jeong
    Park, Sang-Gon
    WORLD JOURNAL OF CLINICAL CASES, 2019, 7 (19) : 3039 - 3046
  • [6] Cost-effectiveness and safety of ramucirumab plus paclitaxel chemotherapy in the treatment of advanced and recurrent gastric cancer
    Kimura, Michio
    Usami, Eiseki
    Teramachi, Hitomi
    Yoshimura, Tomoaki
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (06) : 403 - 411
  • [7] Ramucirumab monotherapy for advanced gastric cancer
    Yaqub, Farhat
    LANCET ONCOLOGY, 2013, 14 (12): : E495 - E495
  • [8] Ramucirumab: A Review in Advanced Gastric Cancer
    Greig, Sarah L.
    Keating, Gillian M.
    BIODRUGS, 2015, 29 (05) : 341 - 351
  • [9] Plasma biomarker dynamics following ramucirumab treatment and survival analysis after ramucirumab treatment failure in patients with advanced gastric cancer.
    Ota, Yumiko
    Wakatsuki, Takeru
    Mashima, Tetsuo
    Takahari, Daisuke
    Chin, Keisho
    Ichimura, Takashi
    Ogura, Mariko
    Matsushima, Tomohiro
    Osumi, Hiroki
    Nakayama, Izuma
    Shinozaki, Eiji
    Suenaga, Mitsukuni
    Kawata, Naomi
    Horiike, Yuki
    Seimiya, Hiroyuki
    Fujita, Naoya
    Yamaguchi, Kensei
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [10] Ramucirumab: A Review in Advanced Gastric Cancer
    Sarah L. Greig
    Gillian M. Keating
    BioDrugs, 2015, 29 : 341 - 351
12345